Anzeige
Mehr »
Sonntag, 26.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13.10.AstraZeneca announces agreement with US government to reduce medicine costs
13.10.Positioning with purpose
10.10.Lilly's Omvoh shows improved outcomes in ulcerative colitis
10.10.Ireland's largest cancer research initiative launches second phase
10.10.Epsilogen appoints Cristina Oliva as chief medical officer
10.10.Setting the direction - how exemplary brand teams brief their agency partners
09.10.MHRA and FDA expand collaboration on AI and medtech regulation
09.10.Lilly appoints former US FDA director Peter Marks to lead infectious disease division
09.10.Speak up to step forward
08.10.Pfizer's Lorviqua recommended by NICE for lung cancer
08.10.Prime welcomes James Karcher to senior leadership team
08.10.Driving launch excellence with agile transformation
07.10.Havas Life London appoints Fran Griffin as Head of Strategy
07.10.New study highlights global overuse of antibiotics for diverticulitis
07.10.The Rashomon Effect
06.10.PMLiVE's T40 - now open for submissions!
06.10.Roche's small cell lung cancer therapy approved by FDA
06.10.Indegene acquires BioPharm to advance AI-driven life sciences marketing
06.10.The impact of US tariffs on healthcare and life sciences multinationals
03.10.Eli Lilly's Inluriyo approved by FDA for breast cancer
03.10.FDA accepts supplemental New Drug Application for Pharming's paediatric immunodeficiency therapy
03.10.Porterhouse appoints Jennifer Stewart as Medical Director in US
03.10.What does it mean to improve outcomes for patients with chronic conditions?
02.10.BMS, Takeda and Astex join AI training consortium
02.10.J&J's Tremfya approved by FDA for children with plaque psoriasis and psoriatic arthritis